Department of Obstetrics & Gynecology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Department of Obstetrics & Gynecology, University Medical Center Leiden, Leiden University, Leiden, the Netherlands.
Eur J Obstet Gynecol Reprod Biol. 2019 Nov;242:79-85. doi: 10.1016/j.ejogrb.2019.09.022. Epub 2019 Sep 23.
Pregnant women with a negative oral glucose tolerance test (OGTT) between 24-28 weeks as part of risk-based screening for gestational diabetes mellitus (GDM) may develop clinical signs or symptoms suggestive for GDM in the third trimester. We aimed to determine the additional yield of repeating an OGTT to detect missed GDM in this group and assess patient characteristics and indications associated with a positive second OGTT.
We conducted a retrospective cohort study of women with a negative OGTT between 24-28 weeks of pregnancy in two hospitals in the Netherlands. Patient characteristics, pregnancy outcomes, OGTT results and indications were compared between women with normal (non-GDM) and abnormal (GDM) results of the second OGTT, using the WHO 1999 criteria (fasting glucose ≥7.0 mmol/L or 2 -h post load ≥7.8 mmol/L). We used receiver operating characteristic (ROC) curve analysis to determine cut-offs for fasting and 2 -h glucose values of the index OGTT that were associated with a positive OGTT in the third trimester.
Of 3147 women at risk for GDM, 183 underwent a second OGTT in the third trimester following their regular OGTT at 24-28 weeks. In 43 women (23.5%) GDM was diagnosed based on the second OGTT. A history of GDM was associated with subsequent GDM diagnosis, with an odds ratio of 2.6 (95% CI 1.0-6.3). Both fasting and 2 -h post load glucose values of the index OGTT were significantly higher in women with abnormal OGTT results later in pregnancy. Index OGTT glucose value cut-offs of 4.8 mmol/L (fasting) and 6.5 mmol/L (2 -h) had positive predictive values of 0.32 and 0.47 for a positive OGTT in the third trimester, and negative predictive values of 0.83 and 0.90, respectively. Fetal growth as a clinical symptom for GDM was the most frequent indication for repeating the OGTT, resulting in the diagnosis of GDM in 22.7% of women tested for this indication.
Repeating an OGTT after initial negative screening results in additional GDM diagnoses. In case of clinical signs, especially in women with additional risk factors such as a history of GDM or higher index OGTT glucose values, repeating an OGTT could be considered.
在进行基于风险的妊娠糖尿病(GDM)筛查时,24-28 周之间的孕妇进行口服葡萄糖耐量试验(OGTT)检测结果为阴性,可能会在孕晚期出现提示 GDM 的临床症状或体征。本研究旨在确定在这一人群中重复 OGTT 以检测漏诊 GDM 的额外收益,并评估与第二次 OGTT 阳性相关的患者特征和指征。
我们对荷兰两家医院的 24-28 周妊娠时 OGTT 检测结果为阴性的孕妇进行了回顾性队列研究。采用世界卫生组织 1999 年标准(空腹血糖≥7.0mmol/L 或 2 小时后负荷血糖≥7.8mmol/L),比较第二次 OGTT 结果正常(非 GDM)和异常(GDM)的孕妇的患者特征、妊娠结局、OGTT 结果和指征。我们使用受试者工作特征(ROC)曲线分析确定与孕晚期 OGTT 阳性相关的指数 OGTT 空腹和 2 小时血糖值的截断值。
在 3147 名 GDM 高危孕妇中,有 183 名在 24-28 周时进行了常规 OGTT 后,在孕晚期进行了第二次 OGTT。根据第二次 OGTT,有 43 名(23.5%)孕妇被诊断为 GDM。GDM 病史与随后的 GDM 诊断相关,比值比为 2.6(95%CI 1.0-6.3)。孕晚期 OGTT 异常的孕妇指数 OGTT 的空腹和 2 小时后负荷血糖值均显著升高。指数 OGTT 空腹血糖值截断值为 4.8mmol/L(4.0mmol/L-5.1mmol/L)和 2 小时后负荷血糖值截断值为 6.5mmol/L(5.8mmol/L-7.1mmol/L)时,对孕晚期 OGTT 阳性的阳性预测值分别为 0.32 和 0.47,阴性预测值分别为 0.83 和 0.90。作为 GDM 的临床症状之一的胎儿生长,是重复 OGTT 的最常见指征,对该指征进行检测的孕妇中有 22.7%被诊断为 GDM。
初次阴性筛查后重复 OGTT 可发现更多的 GDM 诊断。在出现临床症状的情况下,尤其是在存在 GDM 病史或指数 OGTT 血糖值较高等其他危险因素的情况下,可考虑重复 OGTT。